10-KSNDXCIK 0001395937

Syndax Pharmaceuticals Inc

Name: SEC EDGAR filing 0000950170-24-021253
Creator: Syndax Pharmaceuticals Inc
License: https://www.usa.gov/government-works

Annual report (10-K) filed February 27, 2024.

Comprehensive annual report filed by U.S. public companies, including audited financial statements, MD&A, and risk factors.

Read the filing on SEC.gov All documents in this filing

New to the 10-K? What it is and how to read one

Filing facts

Accession number: 0000950170-24-021253
Filer: Syndax Pharmaceuticals Inc
Ticker: SNDX
CIK: 0001395937
Form type: 10-K
Form description: Annual report
Filed at: February 27, 2024
Period of report: December 31, 2023
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 12.3 MB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Syndax Pharmaceuticals Inc

See all 42 filings from Syndax Pharmaceuticals Inc →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1395937/000095017024021253/0000950170-24-021253-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Syndax Pharmaceuticals Inc (0001395937) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.